Tarig Bashir

1.2k total citations
17 papers, 958 citations indexed

About

Tarig Bashir is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Tarig Bashir has authored 17 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Tarig Bashir's work include Cancer-related Molecular Pathways (7 papers), Ubiquitin and proteasome pathways (6 papers) and Virus-based gene therapy research (3 papers). Tarig Bashir is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Ubiquitin and proteasome pathways (6 papers) and Virus-based gene therapy research (3 papers). Tarig Bashir collaborates with scholars based in United States, France and Germany. Tarig Bashir's co-authors include Michele Pagano, Daniele Guardavaccaro, N. Valerio Dorrello, Virginia Amador, Jean Rommelaere, Celina Cziepluch, Mutsumi Miyauchi, Ikuko Ogawa, Shojiro Kitajima and Takashi Takata and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Virology.

In The Last Decade

Tarig Bashir

17 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tarig Bashir United States	14	749	420	237	135	85	17	958
Deborah Silvera United States	11	941 1.3×	227 0.5×	71 0.3×	101 0.7×	179 2.1×	14	1.3k
Matthew W. VanBrocklin United States	15	617 0.8×	275 0.7×	81 0.3×	270 2.0×	126 1.5×	32	1.1k
Nicole Riteco Netherlands	8	795 1.1×	656 1.6×	70 0.3×	242 1.8×	94 1.1×	8	987
Rudolf Hauptmann Austria	15	541 0.7×	147 0.3×	151 0.6×	68 0.5×	84 1.0×	16	1.0k
Romi Gupta United States	19	650 0.9×	215 0.5×	57 0.2×	84 0.6×	185 2.2×	50	945
Martin R. Higgs United Kingdom	18	643 0.9×	309 0.7×	76 0.3×	77 0.6×	89 1.0×	32	968
George Zachos Greece	20	1.2k 1.6×	503 1.2×	661 2.8×	141 1.0×	201 2.4×	40	1.5k
Xavier Chenivesse France	8	767 1.0×	684 1.6×	213 0.9×	144 1.1×	128 1.5×	14	1.2k
Chantal Crémisi France	16	678 0.9×	314 0.7×	70 0.3×	177 1.3×	48 0.6×	28	926
Thomas McGonigal United States	13	541 0.7×	251 0.6×	126 0.5×	40 0.3×	66 0.8×	16	796

Countries citing papers authored by Tarig Bashir

Since Specialization

Citations

This map shows the geographic impact of Tarig Bashir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarig Bashir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarig Bashir more than expected).

Fields of papers citing papers by Tarig Bashir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarig Bashir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarig Bashir. The network helps show where Tarig Bashir may publish in the future.

Co-authorship network of co-authors of Tarig Bashir

This figure shows the co-authorship network connecting the top 25 collaborators of Tarig Bashir. A scholar is included among the top collaborators of Tarig Bashir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarig Bashir. Tarig Bashir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lercher, Lukas, Nina Simon, Andreas Bergmann, et al.. (2022). Identification of Two Non-Peptidergic Small Molecule Inhibitors of CBX2 Binding to K27 Trimethylated Oligonucleosomes. SLAS DISCOVERY. 27(5). 306–313. 5 indexed citations

Auvin, Stéphane, Gisèle Mautino, Florence Jollivet, et al.. (2019). A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells. Life Science Alliance. 2(4). e201800213–e201800213. 13 indexed citations

Lama, Dilraj, Natia Tsomaia, Tarig Bashir, et al.. (2019). Structural insights reveal a recognition feature for tailoring hydrocarbon stapled-peptides against the eukaryotic translation initiation factor 4E protein. Chemical Science. 10(8). 2489–2500. 17 indexed citations

Beke, Lijs, Cenk Kığ, Joannes T. M. Linders, et al.. (2015). MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells. Bioscience Reports. 35(6). 58 indexed citations

Jones, Richard J., Dongmin Gu, Chad C. Bjorklund, et al.. (2013). The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1. Journal of Pharmacology and Experimental Therapeutics. 346(3). 381–392. 24 indexed citations

Ping, Zhen, et al.. (2012). APC/C^Cdh1controls the proteasome-mediated degradation of E2F3 during cell cycle exit. Cell Cycle. 11(10). 1999–2005. 23 indexed citations

Smith, Malcolm A., Richard Görlick, E. Anders Kolb, et al.. (2011). Initial testing of JNJ‐26854165 (Serdemetan) by the pediatric preclinical testing program. Pediatric Blood & Cancer. 59(2). 329–332. 22 indexed citations

Chargari, Cyrus, Eric Angevin, Tarig Bashir, et al.. (2011). Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts. Cancer Letters. 312(2). 209–218. 45 indexed citations

Bashir, Tarig, Julia K. Pagan, Luca Busino, & Michele Pagano. (2010). Phosphorylation of Ser72 is dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its subcellular localization. Cell Cycle. 9(5). 971–974. 31 indexed citations

10.

Kitajima, Shojiro, Yasusei Kudo, Ikuko Ogawa, et al.. (2004). Role of Cks1 Overexpression in Oral Squamous Cell Carcinomas. American Journal Of Pathology. 165(6). 2147–2155. 70 indexed citations

11.

Bashir, Tarig, N. Valerio Dorrello, Virginia Amador, Daniele Guardavaccaro, & Michele Pagano. (2004). Control of the SCFSkp2–Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase. Nature. 428(6979). 190–193. 417 indexed citations

12.

Bashir, Tarig & Michele Pagano. (2004). Don't Skip the G1 Phase: How APC/C^Cdh1Keeps SCF^SKP2in Check. Cell Cycle. 3(7). 848–850. 25 indexed citations

13.

Bashir, Tarig & Michele Pagano. (2003). Aberrant ubiquitin-mediatedproteolysis of cell cycle regulatory proteins and oncogenesis. Advances in cancer research. 88. 101–144. 56 indexed citations

14.

Bashir, Tarig, Jean Rommelaere, & Celina Cziepluch. (2001). In Vivo Accumulation of Cyclin A and Cellular Replication Factors in Autonomous Parvovirus Minute Virus of Mice-Associated Replication Bodies. Journal of Virology. 75(9). 4394–4398. 66 indexed citations

15.

Bashir, Tarig, et al.. (2000). Quantification of human polyomavirus JC in brain tissue and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy by competitive PCR. Journal of Virological Methods. 84(1). 23–36. 19 indexed citations

16.

Bashir, Tarig, et al.. (2000). Cyclin A activates the DNA polymerase δ-dependent elongation machinery in vitro : A parvovirus DNA replication model. Proceedings of the National Academy of Sciences. 97(10). 5522–5527. 65 indexed citations

17.

Simon, Gaëlle, et al.. (1999). Neoplastic Transformation-Associated Stimulation of the In Vitro Resolution of Concatemer Junction Fragments from Minute Virus of Mice DNA. Journal of Virology. 73(3). 2552–2558. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact